GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Net Issuance of Debt

ENCell Co (XKRX:456070) Net Issuance of Debt : ₩-150 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is ENCell Co Net Issuance of Debt?

Net issuance of debt is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive. ENCell Co's net issuance of debt for the three months ended in Mar. 2025 was ₩0 Mil. Its net issuance of debt for the trailing twelve months (TTM) ended in Mar. 2025 was ₩-150 Mil.

ENCell Co Net Issuance of Debt Historical Data

The historical data trend for ENCell Co's Net Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ENCell Co Net Issuance of Debt Chart

ENCell Co Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Net Issuance of Debt
-700.00 -2,000.00 -1,750.00 -300.00 -300.00

ENCell Co Quarterly Data
Dec20 Dec21 Dec22 Mar23 Sep23 Dec23 Mar24 Sep24 Dec24 Mar25
Net Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only -75.00 -75.00 - -75.00 -

ENCell Co Net Issuance of Debt Calculation

This is the cash a company received or spent through debt related activities such as debt issuance or debt repayment. If a company pays down its debt during the period, this number will be negative. If a company issued more debt, it receives cash and this number is positive.

Net Issuance of Debt for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-150 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ENCell Co Net Issuance of Debt Related Terms

Thank you for viewing the detailed overview of ENCell Co's Net Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

ENCell Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ENCell Co Ltd (XKRX:456070) » Definitions » Net Issuance of Debt
Comparable Companies
XKRX:217950 XKRX:083790 XKRX:376270 XKRX:060590 XKRX:174900 XKRX:234690 XKRX:353810 XKRX:278650 XKRX:214260 XKRX:217730 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
701 Yeongdong-daero, 11th floor, Gangnam-gu, Seoul, KOR
Website
http://www.encellinc.com
ENCell Co Ltd is a biopharmaceutical company. The company is engaged in conducting biopharmaceutical contract development and manufacturing (CDMO) service business and cell, gene therapy new drug development business for rare/incurable muscle diseases such as Charcot-Marie-Tooth disease, Duchenne muscular dystrophy, and sarcopenia.

ENCell Co Headlines

No Headlines